PFS
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC (NCT05267366) | Qingdao Central Hospital | 2022-02-01 |
| Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer (NCT05267288) | Qingdao Central Hospital | 2021-02-01 |
| Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell (NCT04520035) | Fudan University | 2020-08-01 |
| Bevacizumab Combined With Gefitinib in the Treatment of Advanced NSCLC (NCT04425187) | Fudan University | 2020-06-08 |
| Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer (NCT02629718) | Sun Yat-sen University | 2015-12-01 |
Track PFS automatically
Every clearance here is in the API, with alerts when new ones post.